scholarly journals 7.1 Development of the Customized Adherence Enhancement Intervention for Adolescents and Young Adults to Improve Medication Adherence in Bipolar Disorder

Author(s):  
Larry Forthun ◽  
Martha Sajatovic ◽  
Avani Modi ◽  
Jennifer Levin ◽  
Melissa DelBello ◽  
...  
Author(s):  
Helen Fogarty ◽  
Alan Gaul ◽  
Saifullah Syed ◽  
Natalija Aleksejenko ◽  
Rosena Geoghegan ◽  
...  

Abstract Introduction SCD patients experience declines in health-related quality of life (HRQOL) domains compared with healthy controls. Despite evidence supporting the benefits of hydroxyurea, medication non-adherence remains problematic, especially in adolescents and young adults (AYA). Adherence barriers include forgetfulness and lack of knowledge. Recently, increased interest in technology-based strategies to improve medication adherence has emerged. No data currently exists on hydroxyurea adherence, HRQOL or perceptions of technology-based tools in the Irish SCD population. Methods In order to interrogate these domains among Irish AYA SCD patients we administered an anonymous survey at two tertiary referral centres in Dublin, Ireland, in July 2019. Results Sixty-three patients participated; 63% female and 37% male, with a median and mean age of 17 and 19 years, respectively. Average monthly adherence was 76% using a visual analogue scale. Recall barriers were present in 62% while 26% omit hydroxyurea for reasons other than forgetting. Reviewing HRQOL; only 36.5% felt always physically able to engage in recreational activities, while 51% experienced disruption to school/college/work due to pain. Eighty-one percent reported that anxiety about health interferes with their lives and non-adherence correlated with worse HRQOL outcomes. Interest in a smartphone app was expressed by the majority, with daily medication reminders being the most popular feature. Sharing adherence data with doctors and discussion forums were less appealing. Conclusions Representing over 10% of the Irish SCD population, our survey provides novel and valuable insights into medication adherence and HRQOL domains. Preferred app features may inform future technology-based interventions to improve medication adherence in SCD and other chronic health conditions.


Cephalalgia ◽  
2018 ◽  
Vol 38 (14) ◽  
pp. 2035-2044 ◽  
Author(s):  
Rachelle R Ramsey ◽  
Christina E Holbein ◽  
Scott W Powers ◽  
Andrew D Hershey ◽  
Marielle A Kabbouche ◽  
...  

Background Effective management of migraine requires adherence to treatment recommendations; however, adolescents with migraine take their daily medications only 75% of the time. Low-cost adherence-focused interventions using technology may improve adherence, but have not been investigated. Methods Thirty-five adolescents and young adults (13–21 years) with migraine participated in an AB-design pilot study to assess the use of a mobile phone adherence-promotion application (“app”) and progressive reminder system. Adherence was calculated using electronic monitoring during the baseline period and medication adherence intervention. Results Relative to baseline, adherence significantly improved during the first month of the intervention. Specifically, improvements existed for older participants with lower baseline adherence. Self-reported app-based adherence rates were significantly lower than electronically monitored adherence rates. Participants rated the intervention as acceptable and easy to use. Conclusions “Apps” have the potential to improve medication adherence and are a promising intervention for adolescents and young adults with low adherence. Involving parents in the intervention is also helpful. Providers should assess barriers to adherence and use of technology-based interventions, encourage parents to incorporate behavioral incentives, and provide referrals for more intensive interventions to improve long-term outcomes. Further, tracking adherence in an app may result in an underestimation of adherence. Future full-scale studies should be conducted to examine adherence promotion app interventions.


2010 ◽  
Vol 14 (4) ◽  
pp. 252-256 ◽  
Author(s):  
Ching-Shu Tang ◽  
Chin-Bin Yeh ◽  
Yu-Shu Huang ◽  
Liang-Jen Wang ◽  
Wen-Jiun Chou ◽  
...  

Author(s):  
David J. Miklowitz ◽  
W. Edward Craighead

Whereas pharmacological interventions remain the primary treatment for bipolar disorder, adjunctive psychosocial interventions have the potential to increase adherence to medication regimens, decrease hospitalizations and relapses, improve quality of life, and enhance mechanisms for coping with stress. Controlled studies have established that individual, family, and group psychoeducation, designed to provide information to bipolar patients and their families about the disorder, its pharmacological treatment, and the treatments’ side effects, leads to lower rates of recurrence and greater adherence to pharmacological treatment among bipolar patients. Type 1 and 2 studies have evaluated cognitive behavioral therapy (CBT) as an ancillary treatment. These studies indicate that CBT is associated with better medication adherence and significantly fewer recurrences and/or rehospitalizations. One Type 1 study has evaluated the effectiveness of IPSRT (interpersonal and social rhythm therapy) for bipolar disorder. IPSRT demonstrated its greatest symptomatic effects during a maintenance treatment period, especially if bipolar patients had been successful in stabilizing their daily and nightly routines during an acute treatment period. Finally, four Type 1 studies in adult and pediatric patients have shown that marital/ family therapy may be effectively combined with pharmacotherapy to reduce recurrences and improve medication adherence and family functioning.


2020 ◽  
Vol 87 (9) ◽  
pp. S416-S417
Author(s):  
Danielle Goldman ◽  
Anjali Sankar ◽  
Lejla Colic ◽  
Linda Spencer ◽  
Cheryl Lacadie ◽  
...  

2004 ◽  
Vol 56 (6) ◽  
pp. 399-405 ◽  
Author(s):  
Barbara K. Chen ◽  
Roberto Sassi ◽  
David Axelson ◽  
John P. Hatch ◽  
Marsal Sanches ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document